Business, Drugs and Pharmaceuticals, Free News Articles, NonProfit and Charities

Leading Companies to Support C Diff Foundation 6th Annual International C.diff. Conference and Health EXPO, Nov. 8-9, Philadelphia

PHILADELPHIA, Pa. -- The C Diff Foundation is honored to welcome leading companies to the 6th Annual International "C.diff. Awareness Conference and Health EXPO," as they come together to make a global difference. These companies are dedicated to the prevention, diagnostics, treatments, environmental safety products and services focused on C.difficile infections and Healthcare-associated infections and whose role serves great importance in the C.diff. community.

The conference takes place on November 8 and 9, 2018 at the Embassy Suites by Hilton Philadelphia Airport Hotel, Philadelphia, Pennsylvania.

"We at Synthetic Biologics are thrilled to partner with the C Diff Foundation in their fight to increase research partnerships, education and advocacy of awareness of Clostridium difficile Infection," said Deb Mathews, PharmD, Vice President, Medical Affairs of Synthetic Biologics. "This conference consistently brings the highest caliber of speakers, rigorously sound clinical data, an impassionate approach and an unyielding commitment in the fight against the incredible unmet medical needs for patients inflicted with and affected by Clostridium difficile Infection."

According to the Centers for Disease Control and Prevention (CDC), Clostridium difficile infection "has become the most common microbial cause of healthcare-associated infections in U.S. hospitals and costs up to $4.8 billion each year in excess health care costs for acute care facilities alone." Statistics provided by the CDC suggest that C. difficile cause nearly 500,000 infections in patients in the U.S. annually and 14,000 deaths a year directly related to this infection.

The 6th Annual International C. diff. Conference & Health EXPO brings together C. diff survivors, physicians, researchers and industry members focused on reducing the major burden of C. difficile infection on global healthcare systems.

"We're privileged to be able to present alongside distinguished C. difficile infection experts and to share with the community our progress on advancing our Phase 3-ready precision antibiotic ridinilazole as a potential new front-line treatment option for patients with C. difficile infection," said Dr. David Roblin, President of R&D of Summit Therapeutics.

With upmost appreciation we thank the following Sponsors for their continued support and partnering with the C Diff Foundation promoting C. diff. awareness worldwide:
- Diamond: Synthetic Biologics.
- Gold: Clorox Healthcare, Seres Therapeutics, ROCHE, Rebiotix, Pfizer.
- Silver: CutisPharma, TechLab, Tru-D Smart UVC, Summit Therapeutics.
- Bronze: Honey Bee Handiworks, Qmetis, Seal Shield, Trinity Guardion, Steriliz RD Rapid UVC, Safety Net America, SporeGen.
- Luncheon: Finch Therapeutics, Synexsis.
- A/V - DaVolterra.

This conference is supported through an educational grant from Sanofi Pasteur US. This activity has been supported by an independent patient advocacy grant from Merck & Co., Inc.

About The C Diff Foundation:

The C Diff Foundation, a 501(c)(3) established 2012, comprised of 100% volunteering professionals dedicated at supporting public health through education and advocating for C. difficile infection (CDI) prevention, treatments, clinical trials, environmental safety, and support worldwide.

Follow C Diff Foundation on Facebook, Instagram.

Twitter @cdiffFoundation #Cdiff2018

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Free News Articles, NonProfit and Charities, Webinars

‘C. diff. Science’ Honors Professionals Dedicated to Clostridium difficile Research and Development

TAMPA, Fla. -- The C Diff Foundation hosts "C. diff. Science" on Sept. 14 to honor professionals dedicated to the scientific research and development in the Clostridium difficile (C. difficile, C. diff.) community worldwide, chaired by Professor Simon M. Cutting, PhD, of Molecular Microbiology at Royal Holloway, University of London.

The free live webinar will take place from 8 a.m. - 12 p.m. ET, Sept. 14, 2017.

Professor Cutting, Event Chair and guest presenter, shares the platform with seven fellow scientists focused on their contributions involving the most common pathogen identified, and leading healthcare-associated infection (HAI) - Clostridium difficile.

C. difficile infections can be acquired and diagnosed in infants and across the life-span with a higher risk involving our senior citizens and that is why it is imperative to learn about a C. difficile infection, its most common symptoms, the treatments available, and environmental safety products to prevent the spread of this spore-bacteria and to help reduce C. difficile infection recurrences.

"On September 14th fellow professionals in the C. diff. community, and those who share a common interest, will have the opportunity to gain knowledge from scientists around the globe who have dedicated their professional lives researching and developing new concepts, new theories, and the progress towards a better understanding - pursuing future developments in Clostridium difficile (a.k.a., C. difficile, C.diff.) infection prevention, treatments, and environmental safety products worldwide," states Nancy C Caralla, Executive Director.

About the C Diff Foundation:

The C Diff Foundation, a 501(c)(3) non-profit, founded in 2012 by Nancy C Caralla, a nurse diagnosed and treated for Clostridium difficile (C. diff.) infections.

Through her own journeys and witnessing the passing of her father diagnosed with sepsis secondary to C. difficile infection involvement, Nancy recognized the need for greater awareness through education, the research being conducted by the government, industry, and academia and better advocacy on behalf of patients, healthcare professionals, and researchers worldwide working to address the public health threat posed by this devastating infection.

For webinar information contact event coordinators: and visit the event website: to register for this free webinar.

For C Diff Foundation information please visit:

Media Contact Person:
Nancy Caralla


Twitter: @cdiffFoundation #CDiffScience

This news story was published by the Neotrope® News Network - all rights reserved.